Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Docusate sodium (either combined with sorbitol or not)

Generic name
Docusate sodium (either combined with sorbitol or not)
Brand name
ATC Code
A06AG10

Pharmacokinetics in children

No information

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Available formulations

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Dosages

Constipation
  • Rectal
    • 1 year up to 6 years
      [3] [4]
      • 30 - 60 mg/dose, once only.
    • 6 years up to 12 years
      [3] [4]
      • 50 - 120 mg/dose, once only.
    • 12 years up to 18 years
      [1] [3] [4]
      • 120 mg/dose, once only.
      • If the effect is insufficient, a further 120 mg can be given the same day or the next day.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Renal impaiment in children > 3 months

GFR ≥10 ml/min/1.73m2: Dose adjustment not required.

GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects in children

Abdominal pain can occur after administration. It usually resolves after 30 minutes

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Contact laxatives
A06AB06
Osmotically acting laxatives
A06AD11
Enemas
A06AG

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

References

  1. Essential Pharma (M) Limited, SPC Norgalax (RVG 14141) 10-01-2019, www.geneesmiddeleninformatiebank.nl
  2. Rademaker C.M.A. et al. . , Geneesmiddelen-Formularium voor Kinderen, 2008
  3. Bekkali NL et al, Rectal fecal impaction treatment in childhood constipation: enemas versus high doses oral PEG, Pediatrics, 2009, Dec;124(6), e1108-15
  4. Tabbers et al, Dutch Paediatric Association guideline " Obstipation in children 0-18 years", www.nvk.nl, 2015

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Changes

Changes